Nigalaye Ashok G (CIK 0001465825)

Latest company ownership

Role: Chief Scientific Officer
Shares held
2,000,000
Last filed at
May 21, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2011Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 29, 2013 Apr 27, 2015 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 43.8 -140,000 -0.46% $11.2K
Mar 11, 2014 Mar 17, 2014 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 22.5 -239,367 -1.17% $144K
Mar 6, 2014 Mar 10, 2014 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 17.5 -1,824,500 -3.19% $1.4M
Jan 13, 2014 Jan 17, 2014 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 22.5 -805,583 -2.38% $147.4K
Jan 3, 2013 Jan 7, 2014 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 22.5 -531,185 -1.57% $79.7K
Nov 15, 2013 Jan 6, 2014 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 36.3 -253,050 -0.74% $29.7K
Nov 26, 2013 Dec 13, 2013 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 36.3 -298,626 -0.69% $37.3K
Dec 2, 2013 Dec 4, 2013 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 43.8 -100,000 -0.47% $12.5K
Nov 11, 2013 Nov 29, 2013 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 32.5 -421,000 -0.65% $50.9K
Nov 14, 2013 Nov 19, 2013 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 22.5 -1,974,140 -2.11% $230.8K
Nov 6, 2013 Nov 8, 2013 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 43.8 -122,200 -0.36% $15.1K
Oct 28, 2013 Oct 30, 2013 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 36.3 -279,300 -0.81% $35.8K
May 9, 2013 May 13, 2013 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 26.3 -391,500 -1.82% $27.8K
Apr 26, 2013 Apr 30, 2013 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Buy 95.0 +4,455,827 26.21% $164.4K
Apr 25, 2013 Apr 29, 2013 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 20.0 -13,891,407 -13.10% $535.2K
Mar 25, 2013 Mar 27, 2013 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Buy 97.5 +6,775,068 42.65% $250K
Mar 21, 2013 Mar 25, 2013 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 20.0 -13,550,136 -46.03% $500K
Jan 22, 2013 Jan 25, 2013 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 26.3 -356,700 -2.61% $32.1K
Jan 11, 2013 Jan 14, 2013 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 22.5 -2,339,000 -23.47% $211.9K
Dec 26, 2012 Dec 31, 2012 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 22.5 -561,000 -5.33% $50.9K
Dec 19, 2012 Dec 21, 2012 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 20.0 -17,248,720 -31.18% $649.8K
May 4, 2012 May 4, 2012 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 20.0 -9,214,097 -24.91% $340K
Apr 18, 2012 Apr 26, 2012 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 20.0 -24,281,850 -39.63% $896K
Mar 23, 2012 Mar 27, 2012 ELITE PHARMACEUTICALS INC /NV/ CFO Sell 20.0 -2,725,000 -4.26% $256.5K
Mar 14, 2012 Mar 20, 2012 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Sell 52.5 -85,000 -0.13% $8.5K
Feb 2, 2011 Mar 17, 2011 ELITE PHARMACEUTICALS INC /NV/ Chief Scientific Officer Buy 91.3 +407,949 100.00% $16.3K